about
Obesity and the risk of heart failureEpidemiology of left ventricular false tendons: clinical correlates in the Framingham Heart Study.Secular trends in echocardiographic left ventricular mass in the community: the Framingham Heart Study.Usefulness of biventricular volume as a predictor of mortality in patients with diabetes mellitus (from the Diabetes Heart Study).Impact of obesity on the risk of heart failure and survival after the onset of heart failure.Atherosclerotic biomarkers and aortic atherosclerosis by cardiovascular magnetic resonance imaging in the Framingham Heart StudyHeart Failure in Women--Insights from the Framingham Heart Study.Antecedent blood pressure, body mass index, and the risk of incident heart failure in later life.Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study.Fatal myocardial rupture after acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALsartan In Acute myocardial iNfarcTion Trial (VALIANT).Differential effects of lipids on the risk of heart failure and coronary heart disease: the Physicians' Health Study.Images in cardiovascular medicine. Rotating fibrocalcific cast after infected pacemaker lead extraction.The Current Focus of Heart Failure Clinical Trials.Long-Term Trends in the Incidence of and Survival with Heart FailureBody Mass Index and Prognosis in Patients With Chronic Heart FailureExtent of coronary artery disease as a predictor of outcomes in acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or bothEffect of antecedent systemic hypertension on subsequent left ventricular dilation after acute myocardial infarction (from the Survival and Ventricular Enlargement trial)Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement TrialChiari Network and Aortic Valve Endocarditis with Concurrent Pulmonary and Systemic EmbolizationCocaine Use and Pulmonary HypertensionThe Epidemiologic Association Between Obesity and Heart Failure
P50
Q28216583-D33C1598-8043-4879-B2FC-755049AE5321Q30481268-738706EE-5433-4F4A-8BCF-89C7D35C811AQ34069733-9F3602B1-A682-4975-AA39-C2E3F3AE825EQ34564186-915060B4-E1C0-483D-9EEC-FD59E1BEF318Q35872536-DD95F67E-EFF0-4DD7-9251-FAD64F789452Q37457593-89206D6D-0101-42BD-BD2A-43CD764C13DFQ37637447-ECDC2738-DEB7-4DC0-BEC8-DFCCD705214CQ40170806-7F6C1CA1-61A8-4FF1-BBCE-E1926F2D4AB4Q40464648-8DBAF6A3-C2BF-4F32-823E-4116D14E71F1Q42990907-C02F7650-432C-48E8-A5D5-07B0A60305FEQ46623894-0173B2FB-67C4-435A-B18F-4A307EE728FFQ47696963-9317AAED-9C76-4CEC-8779-754CB3983803Q52684873-2AF1675F-12AD-4366-8751-C5660F134E5FQ57073236-8279D8A9-3DC2-48D8-988E-63571AC9528FQ57396299-BFD79CBE-E4D9-4142-857E-89D86C84D7C0Q57396319-B48CB398-BCB2-4966-8CF0-41F39B58994BQ80246321-5CE633DE-D4FC-4AEA-AFE5-16CFB601C395Q80446476-68A2A598-8352-43F2-88D5-400F001A5E60Q89098600-D6FD27CA-C043-4982-B15B-BF1FA48CDDDFQ91401725-868AD145-CB7A-48BD-87A2-FDB5EF96C291Q94431257-EFAD805F-5822-4B6F-91D1-775DDD0B0D7B
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Satish Kenchaiah
@ast
Satish Kenchaiah
@en
Satish Kenchaiah
@es
Satish Kenchaiah
@nl
type
label
Satish Kenchaiah
@ast
Satish Kenchaiah
@en
Satish Kenchaiah
@es
Satish Kenchaiah
@nl
prefLabel
Satish Kenchaiah
@ast
Satish Kenchaiah
@en
Satish Kenchaiah
@es
Satish Kenchaiah
@nl
P106
P31
P496
0000-0002-8731-8702